Transparency in decision modelling: What, why, who and how?

Sampson, Christopher James, Arnold, Renee, Bryan, Stirling, Clarke, Philip, Ekins, Sean, Hatswell, Anthony, Hawkins, Neil, Langham, Sue, Marshall, Deborah, Sadatsafavi, Mohsen, Sullivan, Will, Wilson, Edward ORCID: https://orcid.org/0000-0002-8369-1577 and Wrightson, Tim (2019) Transparency in decision modelling: What, why, who and how? PharmacoEconomics, 37 (11). 1355–1369. ISSN 1170-7690

Preview

PDF (Accepted_Manuscript) - Accepted Version Download (710kB) | Preview

Abstract

Transparency in decision modelling is an evolving concept. Recently, discussion has moved from reporting standards to open source implementation of decision analytic models. However, in the debate about the supposed advantages and disadvantages of greater transparency, there is a lack of definition. The purpose of this article is not to present a case for or against transparency, but rather to provide a more nuanced understanding of what transparency means in the context of decision modelling and how it could be addressed. To this end, we review and summarise the discourse to date, drawing on our collective experience. We outline a taxonomy of the different manifestations of transparency, including reporting standards, reference models, collaboration, model registration, peer review, and open source modelling. Further, we map out the role and incentives for the various stakeholders, including industry, research organisations, publishers, and decision-makers. We outline the anticipated advantages and disadvantages of greater transparency with respect to each manifestation, as well as the perceived barriers and facilitators to greater transparency. These are considered with respect to the different stakeholders and with reference to issues including intellectual property, legality, standards, quality assurance, code integrity, health technology assessment processes, incentives, funding, software, access and deployment options, data protection, and stakeholder engagement. For each manifestation of transparency, we discuss the ‘what’, ‘why’, ‘who’, and ‘how’. Specifically, their meaning, why the community might (or might not) wish to embrace them, whose engagement as stakeholders is required, and how relevant objectives might be realised. We identify current initiatives aimed to improve transparency to exemplify efforts in current practice and for the future.

Item Type:	Article
Faculty \ School:	Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups:	Faculty of Medicine and Health Sciences > Research Groups > Health Economics Faculty of Medicine and Health Sciences > Research Groups > Public Health and Health Services Research (former - to 2023)
Depositing User:	LivePure Connector
Date Deposited:	12 Jun 2019 10:30
Last Modified:	21 Jun 2023 11:30
URI:	https://ueaeprints.uea.ac.uk/id/eprint/71335
DOI:	10.1007/s40273-019-00819-z

Downloads

Actions (login required)

View Item